Literature DB >> 29205262

Perceptions on the value of bodily functions in multiple sclerosis.

C Heesen1,2, R Haase3, S Melzig3, J Poettgen1,2, M Berghoff4, F Paul5, U Zettl6, M Marziniak7, K Angstwurm8, R Kern3, T Ziemssen3, J P Stellmann1,2.   

Abstract

BACKGROUND: In neurological diseases presenting with a plethora of symptoms, the value of bodily functions for a given patient might be a guide for clinical management. Multiple sclerosis (MS) is paradigmatic in this respect, and little is known about the value of different bodily functions of patients and their physicians' perceptions.
METHODS: In a multicenter study, 171 patients with relapsing-remitting multiple sclerosis (RRMS), 61% with a clinically active disease within the last 2 years were followed over up to 3 years and yearly patients and their study physician rated on the perceived value of 13 bodily functions via a priority list. Differences between patients and physicians as well as modulating disease demographic factors were analyzed.
RESULTS: Patients with RRMS rated visual function followed by thinking and memory and walking highest while physicians stressed mobility, followed by thinking and memory and alertness most. Ratings were independent from disease duration or disability. Strongest value judgment differences were seen in swallowing regarded more relevant by patients and hand function regarded more relevant by physicians. In general, patients' and physicians' ratings through time were quite stable. Collapsing physical items into a physical functioning scale and mental items in a mental function scale, both dimensions were regarded equally important by patients while physicians underscored physical functioning (P = .016).
CONCLUSION: There are differences between patients and physicians in value statements of bodily functions in MS. In particular, visual functioning is under-recognized by physicians.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  bodily functions; multiple sclerosis; patient perspective; physician perspective; quality of life

Mesh:

Year:  2017        PMID: 29205262     DOI: 10.1111/ane.12881

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  21 in total

Review 1.  Exercise as Medicine in Multiple Sclerosis-Time for a Paradigm Shift: Preventive, Symptomatic, and Disease-Modifying Aspects and Perspectives.

Authors:  Ulrik Dalgas; Martin Langeskov-Christensen; Egon Stenager; Morten Riemenschneider; Lars G Hvid
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-13       Impact factor: 5.081

2.  Hair cortisol concentration, cognitive, behavioral, and motor impairment in multiple sclerosis.

Authors:  Gabriela Magalhães Pereira; Jefferson Becker; Nayron Medeiros Soares; Lucas Araújo de Azeredo; Rodrigo Grassi-Oliveira; Andreo Rysdyk; Rosa Maria Martins de Almeida
Journal:  J Neural Transm (Vienna)       Date:  2019-06-27       Impact factor: 3.575

3.  The subjective minimal important change for the Six Spot Step Test in people with multiple sclerosis - The Danish MS Hospitals Rehabilitation study.

Authors:  Uwe M Pommerich; John Brincks; Anders Guldhammer Skjerbæk; Ulrik Dalgas
Journal:  Acta Neurol Belg       Date:  2022-06-15       Impact factor: 2.471

4.  Objectively assessed physiological, physical, and cognitive function along with patient-reported outcomes during the first 2 years of Alemtuzumab treatment in multiple sclerosis: a prospective observational study.

Authors:  Lars G Hvid; Egon Stenager; Ulrik Dalgas
Journal:  J Neurol       Date:  2022-04-28       Impact factor: 6.682

5.  Delayed access to conscious processing in multiple sclerosis: Reduced cortical activation and impaired structural connectivity.

Authors:  Arzu C Has Silemek; Jean-Philippe Ranjeva; Bertrand Audoin; Christoph Heesen; Stefan M Gold; Simone Kühn; Martin Weygandt; Jan-Patrick Stellmann
Journal:  Hum Brain Mapp       Date:  2021-04-07       Impact factor: 5.038

6.  Data Collection in Multiple Sclerosis: The MSDS Approach.

Authors:  Tjalf Ziemssen; Raimar Kern; Isabel Voigt; Rocco Haase
Journal:  Front Neurol       Date:  2020-06-16       Impact factor: 4.003

7.  Impairment and restrictions in possibly benign multiple sclerosis.

Authors:  Laura Melanie Schaefer; Jana Poettgen; Anja Fischer; Stefan Gold; Jan-Patrick Stellmann; Christoph Heesen
Journal:  Brain Behav       Date:  2019-03-18       Impact factor: 2.708

8.  Joint Healthcare Professional and Patient Development of Communication Tools to Improve the Standard of MS Care.

Authors:  Celia Oreja-Guevara; Stanca Potra; Birgit Bauer; Diego Centonze; Maria-Paz Giambastiani; Gavin Giovannoni; Jürg Kesselring; Dawn Langdon; Sarah A Morrow; Jocelyne Nouvet-Gire; Maija Pontaga; Peter Rieckmann; Sven Schippling; Nektaria Alexandri; Jane Shanahan; Heidi Thompson; Pieter Van Galen; Patrick Vermersch; David Yeandle
Journal:  Adv Ther       Date:  2019-09-05       Impact factor: 3.845

9.  Chances and challenges of a long-term data repository in multiple sclerosis: 20th birthday of the German MS registry.

Authors:  Lisa-Marie Ohle; David Ellenberger; Peter Flachenecker; Tim Friede; Judith Haas; Kerstin Hellwig; Tina Parciak; Clemens Warnke; Friedemann Paul; Uwe K Zettl; Alexander Stahmann
Journal:  Sci Rep       Date:  2021-06-25       Impact factor: 4.379

10.  Psychometric Properties of the SymptoMScreen Questionnaire in a Mild Disability Population of Patients with Relapsing-Remitting Multiple Sclerosis: Quantifying the Patient's Perspective.

Authors:  José Meca-Lallana; Jorge Maurino; Miguel Ángel Hernández-Pérez; Ángel P Sempere; Luis Brieva; Elena García-Arcelay; María Terzaghi; Gustavo Saposnik; Javier Ballesteros
Journal:  Neurol Ther       Date:  2020-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.